Erdheim-Chester disease presenting at the central nervous system.
Sydney M FasuloMina Fransawy AlkomosRovena PjetergjokaErinie M MekhealSharon AwasthiSahithi ChittamuriVinod KumarMehandar KumarAmer AkmalMichael MaroulesPublished in: Autopsy & case reports (2021)
Erdheim-Chester disease is a rare non-Langerhans cell histiocytosis (LCH) that affects different body systems. It was recently recognized as a neoplastic disorder after identifying an activating mutation of the MAPK pathway. Neurological presentations of ECD are rare. We present a case of a 35-year-old male who presented to the emergency department with neck pain, headache and vomiting for 2 months; MRI showed multiple heterogeneous intracranial masses. Neurosurgery performed a suboccipital craniotomy, partially resected the cerebellar mass, and placed a parietal to frontal shunt catheter. Biopsy results from the cerebellar mass demonstrated cerebellar tissue involved by a diffuse proliferation of foamy histiocytes and spindle cells admixed with prominent lymphoplasmacytic infiltrate and positive for CD68, CD163, Factor XIIIa and Fascin. PET scan showed hypermetabolic uptake within the medullary portions of the diffuse abnormal lesions of the distal femurs, tibias, and fibulas, and cardiac MRI was nonsignificant. The patient was started on vemurafenib and continued to show improvement in a 3-month outpatient follow-up.
Keyphrases
- signaling pathway
- contrast enhanced
- emergency department
- induced apoptosis
- computed tomography
- magnetic resonance imaging
- ultrasound guided
- case report
- working memory
- low grade
- fine needle aspiration
- single cell
- oxidative stress
- diffusion weighted imaging
- minimally invasive
- lymph node
- stem cells
- coronary artery
- left ventricular
- magnetic resonance
- pulmonary artery
- pet imaging
- prognostic factors
- adverse drug
- bone marrow
- pulmonary hypertension
- blood brain barrier
- contrast enhanced ultrasound